About US
Contact us
-
Sanofi-Aventis Seeks1 Billion Euro Eye-Care AcquisitionsFrench drug maker Sanofi-Aventis (EPA:SAN) is exploring the possibility to make four acquisitions in the ophthalmology sector for EUR1bn (USD1.35bn) in total, French daily Les Echos reported today, ci2011/2/15
-
Cancer Drug Used in Combination with Other Therapies Associated With Increased Risk of DeathCHICAGO, Feb. 1, 2011—An analysis of previous studies indicates that compared with chemotherapy alone, use of the cancer drug bevacizumab in combination with chemotherapy or biological therapy is asso2011/2/15
-
Three Day Excipient GMP Auditing Workshop- Arlington VATuesday April 5-Thursday April 7, 2011 Three day Workshop Content A comprehensive workshop in excipient auditing for makers and users. Training will analyze the essential elements of excipient g2011/2/15
-
Another Recall for McNeilJ&J sales affected by recalls, plant shutdown The new year brought news of yet another recall for McNeil Consumer Healthcare, a subsidiary of Johnson & Johnson (J&J) of New Brunswick, N.J2011/2/12
-
Sanofi-Aventis Q4 Sales UpFrench drug manufacturer Sanofi-Aventis reported sales of €7.39bn in the fourth quarter of 2010, up 0.5% on last year's figures. Exchange rate movements had a favourable effect, amounting to 6.4%, w2011/2/12
-
FDA Approves First Drug to Reduce Preterm Delivery RiskThe US Food and Drug Administration (FDA) has approved the Makena (hydroxyprogesterone caproate) injection, which can reduce the risk of preterm delivery. The drug is intended for use in pregnant wo2011/2/11
-
GlaxoSmithKline Faces Legal Action Over Parkinson's DrugGlaxoSmithKline could face legal action after its Requip drug, taken by Parkinson's disease sufferers, was said to cause gambling addiction. A man from the UK is the latest patient to complain about2011/2/11
-
Global Health Consortium to support development of vaccines to control dengue feverGlobal Health Consortium will raise the profile of dengue and promote prevention through vaccinationThe International Vaccine Institute (IVI) today announced the launch of the Dengue Vaccine Initiativ2011/2/11
-
Three government agencies jointly issue notice on strengthening the supervision of prepared slices of Chinese crude drugsTo further intensify the supervision to the prepared slices of Chinese crude drugs and promote the sound development of traditional Chinese medicine, the State Food and Drug Administration, the Minist2011/2/9
-
FDA Grants Orphan Drug Designation to Bayer's Investigational Compound Regorafenib for the Treatment of Gastrointestinal Stromal TumorsWAYNE, N.J., Feb. 4, 2011 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc. announced today that its investigational compound regorafenib (BAY 73-4506) has been granted orphan drug status2011/2/9